Torezolid是一种新型恶唑烷酮，可与核糖体50S亚基的23S核糖体RNA结合抑制细菌的蛋白质合成。

Tedizolid is an Oxazolidinone Antibacterial. The mechanism of action of tedizolid is as a Breast Cancer Resistance Protein Inhibitor.

Tedizolid (0.25 μg/mL) inhibits all 28 clinical isolates of PRSP which is 4-fold more potent than linezolid against PRSP[1].

The tedizolid phosphate at a minimum total daily dose of 10 mg/kg achieved a 100% survival rate for mice infected with PSSP type III. Lungs of infected mice treated with tedizolid phosphate show less severe inflammation and edema, as indicated by the mean scores for inflammation and edema[1].

856866-72-3

C17H15FN6O3

370.34

DA-7157;泰地唑利;Torezolid;特地唑胺;TR 700

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years